Skip to main content

JPMORGAN CHASE & CO

Position in MYGN — Myriad Genetics Inc

CIK 19617 NEW YORK, NY

Position in MYGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,187,392
-$1,150,025 QoQ
Shares Held
263,865
-30.6% QoQ
Ownership
0.279%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $13,314,994,703 across 38 Diagnostics & Research names. MYGN ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,187,392 263,865
2025-12-31 $2,337,417 380,068
2025-09-30 $3,992,635 552,232
2025-06-30 $3,534,174 665,570
2025-03-31 $4,870,585 549,108
2024-12-31 $5,830,093 425,244
2024-09-30 $15,506,298 566,130
2024-06-30 $14,033,214 573,721
2024-03-31 $2,235,911 104,874
2023-12-31 $2,830,805 147,900
2023-09-30 $2,152,038 134,167
2023-06-30 $3,098,655 133,678
2023-03-31 $3,667,134 157,862
2022-12-31 $2,041,353 140,686
2022-09-30 $3,093,878 162,153
2022-06-30 $5,433,791 299,053
2022-03-31 $19,909,082 790,043
2021-12-31 $19,664,750 712,491
2021-09-30 $24,144,135 747,728
2021-06-30 $24,260,091 793,332
2021-03-31 $8,543,233 280,566
2020-12-31 $7,198,710 364,123
2020-09-30 $8,855,214 679,081
2020-06-30 $5,101,944 449,907
2020-03-31 $4,673,672 326,602